miR-92b-3p acts as a tumor suppressor by inhibiting the expression of GABRA3, a transporter that is known to have abnormal expression in breast, pancreatic, and lung cancer [34,35]; it may also be abnormally overexpressed in other types of cancers, meaning that miR-92b-3p loaded into EVs could have translational applications for more than just one type of cancer. Here, GABRA3 is linked to cancer.